About The Medical Condition Drug Evaluation, FDA Phase 2

ClusterMed
  1. ClusterMed.info
  2. Medical Conditions
  3. D Illnesses And Diseases
  4. Dr
  5. Drug Evaluation, FDA Phase 2

Find the definition of the medical term Drug Evaluation, FDA Phase 2. Drug Evaluation, FDA Phase 2 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

Drug Evaluation, FDA Phase 2

Drug Evaluation, FDA Phase 2 Medical Condition Defined & Explained
Drug Evaluation, FDA Phase 2 Medical Condition

What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase 2?

Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day